Opinion|Videos|June 28, 2024
Current Landscape of Biosimilar Use in US Healthcare Space
Dr Humphreys drives a conversation scoping the biosimilar landscape and available treatment options.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Provide an overview of the current landscape of FDA biosimilar approvals. What biosimilars are available? What trends are you seeing?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
3
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
4
ICER Draft Flags High Cost of New Hypertension Drug Class
5